Company Information & Drug Savings for Otsuka Pharmaceutical Medications

Otsuka Pharmaceutical is a Japanese pharmaceutical company with significant US operations in mental health, nephrology, and oncology. Key products include Abilify (aripiprazole) and Rexulti (brexpiprazole) for schizophrenia and depression, Jynarque for autosomal dominant polycystic kidney disease, and Lonsurf for colorectal and gastric cancers. Otsuka’s CNS expertise advances treatments for serious psychiatric disorders.

Otsuka Pharmaceutical

How to Contact Otsuka Pharmaceutical

Browse Medications Manufactured by Otsuka Pharmaceutical

Medical Disclaimer

NowPatient has taken all reasonable steps to ensure that all material is factually accurate, complete, and current. However, the knowledge and experience of a qualified healthcare professional should always be sought after instead of using the information on this page. Before taking any drug, you should always speak to your doctor or another qualified healthcare provider.

The information provided here about medications is subject to change and is not meant to include all uses, precautions, warnings, directions, drug interactions, allergic reactions, or negative effects. The absence of warnings or other information for a particular medication does not imply that the medication or medication combination is appropriate for all patients or for all possible purposes.

Experienced a Side Effect?

Report to

👉
Yellowcard logo
(UK)
👉
Medwatch logo
(US)
NowPatient - Report Side Effects to Yellow Card or MedWatch